Surgical Management of Placenta Accreta
September 13, 2018 updated by: Mitri Rashed, Royal Medical Services, Jordanian Armed Forces
Surgical Management of Placenta Accreta a Three Year Experience at King Hussein Medical Center
purpose of this study was to report our experience for surgical management of suspected placenta accreta cases encountered in King Hussein medical center
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
was a retrospective study of all patients who underwent planned deliveries for placenta accreta at King Hussein Medical Centre (KHMC) from August 2011 to October 2014.Demographic characteristics were recorded.
Ultrasound (U/S) and magnetic resonance imaging (MRI) were used for the diagnosis.
Surgery for all patients were performed by multidisciplinary teams.
All information were obtained from patient's files.
Study Type
Observational
Enrollment (Actual)
40
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
All pregnant ladies who were diagnosed to have placenta previa accreta cases which was diagnosed using ultrasound or MRI
Description
Inclusion Criteria:
- all placenta previa accreta cases encountered in our institution over three year period
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The intraoperative and short term postoperative complications of surgical interventions in placenta accreta
Time Frame: 48 hours
|
Intraoperative visceral injuries, bleeding, and short term postoperative morbidity and mortality
|
48 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2011
Primary Completion (Actual)
October 30, 2014
Study Completion (Actual)
November 30, 2017
Study Registration Dates
First Submitted
September 11, 2018
First Submitted That Met QC Criteria
September 11, 2018
First Posted (Actual)
September 13, 2018
Study Record Updates
Last Update Posted (Actual)
September 17, 2018
Last Update Submitted That Met QC Criteria
September 13, 2018
Last Verified
September 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RoyalMSJordan
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bakrey balloon insertion within the uterus and caesarean hysterectomy
-
University Hospital, MontpellierNot yet recruitingEustachian Tube Dysfunction
-
Memorial Sloan Kettering Cancer CenterCompletedBreast Cancer | Atrophic VaginitisUnited States